Breast cancer screening can be confusing. Shero Imaging’s mission is to make it less confusing and to give you clear steps for the future. Patients can schedule a consultation BEFORE ...

Cancer is a universal issue which affects many people around the world. Many will turn to surgery in the hope a surgeon will ...

Can AI match radiologists in prostate MRI diagnosis? The PARADIGM trial will assess AI detection of clinically significant ...

FDA approves Pylarify TruVu, a new prostate cancer PET imaging agent designed to expand access and improve detection of recurrent or metastatic disease.

Manufacturing optimization is projected to expand batch output by ~50%, improving supply reliability and supporting higher-throughput PSMA PET imaging services. Increased radioactivity extends shelf ...

Cancer imaging is entering a phase where malignant cells no longer hide in murky grayscale but flare into view with surgical precision. Across operating rooms, scanners, and even blood tests, ...

An MRI is an effective test for detecting cancer in many parts of the body. It’s especially helpful at creating detailed images of soft tissue, including tumors. However, there are some types of ...

By Puyaan Singh and Sahil Pandey March 6 (Reuters) - The U.S. Food and Drug Administration on Friday approved a new formulation of Lantheus Holdings' prostate cancer imaging agent, aimed at improving ...

Medical imaging foundation models are ushering in a new era for precision oncology. By integrating massive multimodal datasets and advanced AI algorithms, these models achieve unprecedented accuracy ...

For years, routine screening recommendations have been limited to four cancers — breast, cervical, colorectal, and high-risk ...

Telix Pharmaceuticals focuses on radiopharmaceuticals for the diagnosis and treatment of cancer.